Still Smokin' - Research Report on Lorillard Inc., Schweitzer-Mauduit International Inc., Reynolds American Inc., Altria Group, Inc. and Philip Morris International Inc.

NEW YORK, February 28, 2013 /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting Lorillard Inc. (NYSE: LO), Schweitzer-Mauduit International, Inc. (NYSE: SWM), Reynolds American, Inc. (NYSE: RAI), Altria Group, Inc. (NYSE: MO) and Philip Morris International Inc. (NYSE: PM). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Lorillard Inc. Research Report

Despite the heightened competitive environment, Lorillard managed to deliver solid financial and market share results for both the fourth quarter and full year of 2012. "We are very pleased to have delivered a double-digit shareholder return as measured by EPS growth and the dividend yield during 2012 and to have grown market share for the tenth consecutive year," announced Murray S. Kessler , Lorillard Chairman President and CEO. These results raised the company's dividends by 6.5%. Lorillard is home to the Newport, Kent, True, Maverick and Old Gold cigarette brands. The Full Research Report on Lorillard Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/d3cd_LO]

--

Schweitzer-Mauduit International, Inc. Research Report

In response to a number of countries having set safety performance standards for fire prevention, SWM is leading the way in LIP innovation. SWI's Lower Ignition Propensity (LIP) banding papers make use of Alginex water-based technology. This technology uses an all-natural alginate solution derived from seaweed instead of harsh solvents. It lets the company's designers to create cigarettes that meet global Fire Safety Complaint standards with a low FASE (Free Air Self Extinguishment) percentage while still delivering the smoking experience that their customers want. The Full Research Report on Schweitzer-Mauduit International, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/0a0e_SWM]

--

Reynolds American, Inc. Research Report

In line to educate wholesalers and retailers on tobacco tax issues, Reynolds has changed its non-corporate website http://www.nocigtax.com to http://www.transformtobacco.com. The new site has also been updated to reflect the company's strategic framework that revolves around three key transformation pillars: Tobacco Harm Reduction, Commercial Integrity and Youth Tobacco Prevention. The website will serve as an education and activation tool on other critical tobacco-related issues that can severely affect the industry, as well as an information board on cigarette excise tax. It is also a mobile-friendly device with an interactive state-by-state map with key information, social media links, and fully updated content on tobacco-related issues. The Full Research Report on Reynolds American, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/49dd_RAI]

--

Altria Group Inc. Research Report

Despite improvements in certain economic indicators, Altria still remains cautious for the 2013 business environment, especially when tobacco products still remain a target for excise tax increases. Altria's Chairman and CEO Marty Barrington forecasts its 2013 full-year guidance for reported diluted earnings per share (EPS) in a $2.34-$2.40 range. This reflects estimated SABMiller plc. special items. This does not reflect the potential impact of PM USA's agreement to resolve the NPM adjustment disputes. The Full Research Report on Altria Group Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/04bf_MO]

--

Philip Morris International Inc. Research Report

Philip Morris is kicking off a round of clinical studies in regards to new tobacco products. The company plans to commercialize these products as soon as 2016. "We are initiating eight clinical studies this year in different locations and with different population groups and plan to expand the testing in 2014," said Chief Financial Officer Jacek Olczak during a presentation at the Consumer Analyst Group of New York conference in Boca Raton, Florida. Analysts are keeping an eye out on this since the company has a good track record when it comes to new-product development. This step comes in line with the company's other business developments such as smokeless tobacco products. The Full Research Report on Philip Morris International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/b730_PM]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.

Contact: Patricia Byers
Email: press@investors-alliance.com
Main: +1(408)745-7826

SOURCE Investors-Alliance